ArticleIndian journal of psychiatry2026
Feasibility and safety of home-based alcohol detoxification via teleconsultation in India.
Article in Indian journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Access to medically supervised alcohol withdrawal management is limited in low-resource settings. We implemented a structured, home-based alcohol withdrawal program using telemedicine-Telemedicine-Assisted Ambulatory Management of Alcohol withdrawal (TAMAL). Aim: This study aimed to evaluate the feasibility, safety, and acceptability of TAMAL using retrospective clinical records. Methods: This was a retrospective observational study conducted at an addiction treatment center in North India. Records of 20 adult male patients diagnosed with alcohol dependence syndrome (ICD-10) and enrolled in the TAMAL program between October 2023 and June 2024 were reviewed. All patients underwent an in-person clinical assessment on Day 1, followed by daily teleconsultations (Days 2-6) for symptom-guided chlordiazepoxide titration using the CIWA-Ar scale. Sociodemographic and clinical variables, CIWA-Ar scores, medication use, adherence, adverse events, and patient satisfaction were extracted from clinical records. Results: The mean CIWA-Ar score decreased from 8.5 (SD = 3.22) on Day 1 to 0 by Day 4. Sixteen patients (80%) were classified as quick responders with rapid dose tapering; three required extended benzodiazepine support. No seizures or delirium occurred. One patient was lost to follow-up. Satisfaction was high in 74% of participants. Three (15%) reported alcohol use during the follow-up period, and 19 (95%) patients returned on the seventh day for in-person follow-up. Conclusion: This preliminary retrospective review suggests that telemedicine-assisted ambulatory alcohol withdrawal management is feasible and safe in carefully selected patients. Structured protocols and family support may enable the delivery of detoxification services in home settings where access to inpatient care is limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.